Correlation Between Vg Life and Sino Biopharmaceutica

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vg Life and Sino Biopharmaceutica at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vg Life and Sino Biopharmaceutica into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vg Life Sciences and Sino Biopharmaceutical Ltd, you can compare the effects of market volatilities on Vg Life and Sino Biopharmaceutica and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vg Life with a short position of Sino Biopharmaceutica. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vg Life and Sino Biopharmaceutica.

Diversification Opportunities for Vg Life and Sino Biopharmaceutica

0.15
  Correlation Coefficient

Average diversification

The 3 months correlation between VGLS and Sino is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding Vg Life Sciences and Sino Biopharmaceutical Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sino Biopharmaceutical and Vg Life is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vg Life Sciences are associated (or correlated) with Sino Biopharmaceutica. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sino Biopharmaceutical has no effect on the direction of Vg Life i.e., Vg Life and Sino Biopharmaceutica go up and down completely randomly.

Pair Corralation between Vg Life and Sino Biopharmaceutica

Given the investment horizon of 90 days Vg Life Sciences is expected to generate 102.93 times more return on investment than Sino Biopharmaceutica. However, Vg Life is 102.93 times more volatile than Sino Biopharmaceutical Ltd. It trades about 0.27 of its potential returns per unit of risk. Sino Biopharmaceutical Ltd is currently generating about 0.09 per unit of risk. If you would invest  0.00  in Vg Life Sciences on September 4, 2024 and sell it today you would earn a total of  0.01  from holding Vg Life Sciences or generate 9.223372036854776E16% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy98.44%
ValuesDaily Returns

Vg Life Sciences  vs.  Sino Biopharmaceutical Ltd

 Performance 
       Timeline  
Vg Life Sciences 

Risk-Adjusted Performance

20 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Vg Life Sciences are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak essential indicators, Vg Life unveiled solid returns over the last few months and may actually be approaching a breakup point.
Sino Biopharmaceutical 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Sino Biopharmaceutical Ltd are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent primary indicators, Sino Biopharmaceutica showed solid returns over the last few months and may actually be approaching a breakup point.

Vg Life and Sino Biopharmaceutica Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vg Life and Sino Biopharmaceutica

The main advantage of trading using opposite Vg Life and Sino Biopharmaceutica positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vg Life position performs unexpectedly, Sino Biopharmaceutica can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sino Biopharmaceutica will offset losses from the drop in Sino Biopharmaceutica's long position.
The idea behind Vg Life Sciences and Sino Biopharmaceutical Ltd pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Other Complementary Tools

Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas